99 related articles for article (PubMed ID: 2598325)
1. Synthesis and biological activities of optical isomers of 2-(4-diphenylmethyl-1-piperazinyl)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate (manidipine) dihydrochloride.
Kajino M; Wada Y; Nagai Y; Nagaoka A; Meguro K
Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2225-8. PubMed ID: 2598325
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological effects of optically active 2-[4-(4-benzhydryl-1-piperazinyl)phenyl]-ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate hydrochloride.
Ashimori A; Uchida T; Ohtaki Y; Tanaka M; Ohe K; Fukaya C; Watanabe M; Kagitani M; Yokoyama K
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):108-11. PubMed ID: 2049794
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activities of optical isomers of 2-(4-diphenylmethyl-1-piperazinyl)ethyl 5-(4,6-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate dihydrochloride (NIP-101).
Sakoda R; Kamikawaji Y; Seto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2370-6. PubMed ID: 1446357
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and crystal structure of optically active 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate (NZ-105).
Sakoda R; Matsumoto H; Seto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2377-81. PubMed ID: 1446358
[TBL] [Abstract][Full Text] [Related]
5. Novel 1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive activity of 3-[4-(substituted amino)phenylalkyl]ester derivatives.
Ashimori A; Ono T; Inoue Y; Morimoto S; Eda M; Uchida T; Ohtaki Y; Fujino Y; Kido H; Ogura Y
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):91-9. PubMed ID: 2049813
[TBL] [Abstract][Full Text] [Related]
6. Permanently charged chiral 1,4-dihydropyridines: molecular probes of L-type calcium channels. Synthesis and pharmacological characterization of methyl(omega-trimethylalkylammonium) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate iodide, calcium channel antagonists.
Peri R; Padmanabhan S; Rutledge A; Singh S; Triggle DJ
J Med Chem; 2000 Jul; 43(15):2906-14. PubMed ID: 10956198
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological activity of stereoisomers of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 1-(phenylmethyl)-3-piperidinyl ester.
Muto K; Kuroda T; Kawato H; Karasawa A; Kubo K; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1662-5. PubMed ID: 3219137
[TBL] [Abstract][Full Text] [Related]
8. Design of an antithrombotic-antihypertensive agent (Wy 27569). Synthesis and evaluation of a series of 2-heteroaryl-substituted dihydropyridines.
Archibald JL; Bradley G; Opalko A; Ward TJ; White JC; Ennis C; Shepperson NB
J Med Chem; 1990 Feb; 33(2):646-52. PubMed ID: 2299629
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
Wada K; Nakamura S; Morishita S; Kanda M; Matsui H; Fukata F; Shirahase H
Arzneimittelforschung; 1994 Oct; 44(10):1112-6. PubMed ID: 7818582
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) and its crystal structure.
Sakoda R; Kamikawaji Y; Seto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2362-9. PubMed ID: 1446356
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure, and pharmacological evaluation of the stereoisomers of furnidipine.
Alajarin R; Vaquero JJ; Alvarez-Builla J; Pastor M; Sunkel C; Fau de Casa-Juana M; Priego J; Statkow PR; Sanz-Aparicio J; Fonseca I
J Med Chem; 1995 Jul; 38(15):2830-41. PubMed ID: 7636844
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel 2-chloro-1,4-dihydropyridines by chlorination of 2-hydroxy-1,4-dihydropyridines with phosphorus oxychloride.
Cho H; Ueda M; Mizuno A; Ishihara T; Aisaka K; Noguchi T
Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2117-21. PubMed ID: 2598311
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis and comparative pharmacological studies of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylates with non-identical ester functions (author's transl)].
Meyer H; Bossert F; Wehinger E; Stoepel K; Vater W
Arzneimittelforschung; 1981; 31(3):407-9. PubMed ID: 7194663
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. I.
Morita I; Tada S; Kunimoto K; Tsuda M; Kise M; Kimura K
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3898-904. PubMed ID: 3435985
[No Abstract] [Full Text] [Related]
15. Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing nitrooxyalkylester moieties at the 3- and 5-positions.
Ogawa T; Nakazato A; Tsuchida K; Hatayama K
Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1049-54. PubMed ID: 8370105
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. II.
Morita I; Kunimoto K; Tsuda M; Tada S; Kise M; Kimura K
Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4144-54. PubMed ID: 3435941
[No Abstract] [Full Text] [Related]
17. Synthesis and antihypertensive activity of 4-(1,2-dihydro-2-oxo-1-pyridyl)-2H-1-benzopyrans and related compounds, new potassium channel activators.
Bergmann R; Gericke R
J Med Chem; 1990 Feb; 33(2):492-504. PubMed ID: 2299619
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of the calcium modulator (R) and (S)-3-methyl 5-pentyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.
Zhang BL; He W; Shi X; Huan ML; Huang QJ; Zhou SY
Bioorg Med Chem Lett; 2010 Feb; 20(3):805-8. PubMed ID: 20064722
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
[TBL] [Abstract][Full Text] [Related]
20. Syntheses and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. III.
Morita I; Haruta Y; Tomita T; Tsuda M; Kandori K; Kise M; Kimura K
Chem Pharm Bull (Tokyo); 1987 Dec; 35(12):4819-28. PubMed ID: 3451803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
